初始血管与足部干预后重新分期WIfI(伤口、缺血、足部感染)的价值
再分期改善、不变、恶化组分别占48%、32%、20%,三组30天主要不良肢体事件率和5年无主要不良肢体事件生存率、无截肢生存率均有差异。
要点
- 再分期后48%患者WIfI改善、32%不变、20%恶化。
- 30天主要不良肢体事件率改善组5%、不变组9%、恶化组24%(P=0.01)。
- 5年无主要不良肢体事件生存率改善组47±5%、不变组38±5%、恶化组23±9%(P=0.001)。
核心结论
- 初始血管与足部干预后重新分期WIfI可显著降低WIfI分期,更好区分30天结局,并影响无主要不良肢体事件生存率和无截肢生存率。
主要发现
- 初始表现时37%患者为WIfI 3期,63%为WIfI 4期;多数患者为GLASS III期解剖病变。
- 56%患者接受初始感染控制手术,78%接受血管干预(71%腔内干预,29%开放旁路)。
- 再分期后48%患者改善、32%不变、20%恶化。
- 30天主要不良肢体事件率改善组5%、不变组9%、恶化组24%(P=0.01);30天大截肢率改善组2%、不变组3%、恶化组14%(P<0.02)。
- 5年无主要不良肢体事件生存率改善组47±5%、不变组38±5%、恶化组23±9%(P=0.001);5年无截肢生存率改善组49±5%、不变组33±5%、恶化组19±6%(P=0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Wound, ischemia, and foot infection (WIfI) is an important staging system for diabetic patients presenting with chronic limb-threatening ischemia (CLTI) of the lower extremities (LEs). This study examines the clinical implications of restaging WIfI after initial vascular and podiatric interventions. METHODS: A prospective database of patients undergoing vascular intervention treatment of the LE for tissue loss between 2018 and 2022 was queried. Cases were reviewed and staged preoperatively according to WIfI and then based on the WIfI restaging after primary vascular and podiatric interventions. Three groups were identified as follows: improvement of WIfI score (improved), WIfI unchanged (no change), and deterioration of WIfI score (worsened) groups. In cases of active infection, patients underwent infection control (drainage and/or amputation) followed by revascularization (endovascular or open intervention). In contrast, patients with no active infection underwent revascularization followed by podiatric intervention. Amputation-free survival (AFS; survival without major amputation) and freedom from major adverse limb events (MALE; above-ankle amputation of the index limb or significant reintervention [new bypass graft or jump or interposition graft revision]) were evaluated. RESULTS: One thousand four hundred and four patients (61% male, age 64 ± 12 years, mean ± SD) presented with CLTI underwent initial vascular and/or podiatric LE interventions. On initial presentation, 37% of the patients presented with WIfI stage 3, and 63% presented with WIfI stage 4. The majority of the patients had Global Limb Anatomic Staging System (GLASS) stage III anatomic disease. Fifty-six percent of the patients had a primary infection control procedure, and 78% had a vascular intervention (71% endovascular intervention and 29% open bypass). After completing the primary podiatric and vascular procedures and restaging the WIfI score, 48% of the patients were improved, 32% were unchanged, and 20% were worsened. The postoperative change in WIfI classification impacted both 30-day rate of MALE (5% vs. 9% vs. 24% for the improved, unchanged, and worsened groups, respectively; P = 0.01) and the 30-day rate of major amputation (2% vs. 3% vs. 14% for the improved, unchanged, and upgraded groups, respectively; P < 0.02). At 5 years, freedom from MALE was progressively worse in the improved, unchanged, and worsened groups (47 ± 5% vs. 38 ± 5% vs. 23 ± 9%, respectively; mean ± standard error of the mean (SEM), P = 0.001). The 5-year AFS also deteriorated for the improved, unchanged, and worsened groups (49 ± 5% vs. 33 ± 5% vs. 19 ± 6%, respectively; mean ± SEM, P = 0.001) CONCLUSIONS: Restaging WIfI after primary vascular and podiatric intervention results in significant downgrading of WIfI staging, allows for better differentiation of 30-day outcomes, and influences freedom from MALE and AFS outcomes.
引用
- Cheun TJ, Hart JP, Davies MG, et al. The Value of Restaging WIfI (Wound, Ischemia, and Foot Infection) After Initial Vascular and Podiatric Intervention. Ann Vasc Surg. 2024. PMID: 39581319. doi:10.1016/j.avsg.2024.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。